Literature DB >> 1733909

Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acid.

H Hiel1, A Schamel, J P Erre, T Hayashida, D Dulon, J M Aran.   

Abstract

Guinea pigs (GPs) receiving one intra-muscular injection of gentamicin (GM) (150 mg/kg) in which 2 mg of tritiated GM (2 mCi) were incorporated, followed 1.5 h later by an intra-cardiac injection of ethacrynic acid (EA) (30 mg/kg) were sacrificed 25 min, 1, 4 and 24 h after the EA injection. Other GPs were treated with one injection of GM or EA alone and sacrificed 24 h later. Cochlear function was monitored by recording VIIIth nerve compound action potential (CAP) responses to clicks at 70 dB peak-equivalent Sound Pressure Level (pe SPL) and CAP audiograms. At 24 h thresholds were significantly elevated for high frequencies only in GPs treated with the GM/EA combination. GM was revealed in the cochlea and kidney by autoradiography using light and electron microscopy. In the kidney GM was already detected in the proximal tubule cells at 25 min and at 24 h. In the cochlea GM was systematically not observed at 25 min. At 1 h a weak labelling was detected in vessels of the stria vascularis and in sensory cells at the base of the cochlea. At 4 h the labelling disappeared in stria vascularis but increased in the hair cells. At 24 h GM labelling was found exclusively in hair cells, particularly outer hair cells, with a gradient from base to apex and from first to 3rd row, this distribution pattern correlating well with the pattern of threshold changes prominent at high frequencies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733909     DOI: 10.1016/0378-5955(92)90148-g

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  21 in total

1.  Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis.

Authors:  Sigrid E Myrdal; Katherine C Johnson; Peter S Steyger
Journal:  Hear Res       Date:  2005-06       Impact factor: 3.208

2.  Pharmacokinetics of Drug Entry into Cochlear Fluids.

Authors:  Alec N Salt
Journal:  Volta Rev       Date:  2005

3.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

4.  Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.

Authors:  Keiko Hirose; Eisuke Sato
Journal:  Hear Res       Date:  2010-10-31       Impact factor: 3.208

Review 5.  New developments in aminoglycoside therapy and ototoxicity.

Authors:  Jing Xie; Andra E Talaska; Jochen Schacht
Journal:  Hear Res       Date:  2011-05-27       Impact factor: 3.208

6.  Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid.

Authors:  Dalian Ding; Haiyan Jiang; Richard J Salvi
Journal:  Hear Res       Date:  2009-08-26       Impact factor: 3.208

7.  Systemic Fluorescent Gentamicin Enters Neonatal Mouse Hair Cells Predominantly Through Sensory Mechanoelectrical Transduction Channels.

Authors:  Ayane Makabe; Yoshiyuki Kawashima; Yuriko Sakamaki; Ayako Maruyama; Taro Fujikawa; Taku Ito; Kiyoto Kurima; Andrew J Griffith; Takeshi Tsutsumi
Journal:  J Assoc Res Otolaryngol       Date:  2020-03-09

8.  TRPV4 enhances the cellular uptake of aminoglycoside antibiotics.

Authors:  Takatoshi Karasawa; Qi Wang; Yi Fu; David M Cohen; Peter S Steyger
Journal:  J Cell Sci       Date:  2008-08-05       Impact factor: 5.285

9.  Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics.

Authors:  Hongzhe Li; Peter S Steyger
Journal:  Noise Health       Date:  2009 Jan-Mar       Impact factor: 0.867

10.  Specific glutathione-SH inhibition of toxic effects of metabolized gentamicin on isolated guinea pig hair cells.

Authors:  H P Zenner; S Keiner; U Zimmermann
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.